Cerebras Systems IPO: the $5.55B wafer-scale AI chip debut

Cerebras's pitch is hardware heresy: instead of slicing a silicon wafer into hundreds of small dies and stitching them back together with packaging and interconnect, the company etches a single chip across an entire wafer. The result, the Wafer Scale Engine 3, is about 58 times larger than a leading GPU and keeps compute, memory, and bandwidth co-located on one piece of silicon — a layout the company says delivers up to 15x faster inference than GPU clusters and roughly 1,000x the memory bandwidth of Nvidia's Rubin generation ^[1][2].

The public market priced that pitch like a general-purpose Nvidia challenger. Sell-side research is less convinced. Davidson analysts called the product 'niche-y,' arguing wafer-scale wins decisively on single-large-model inference but struggles to compete in the broader training and mixed-workload markets where GPUs and hyperscaler ASICs dominate ^[1]. That tension — a niche architecture priced at a broad-market multiple — is the cleanest explanation for the roughly 10% pullback the day after the debut ^[3]. Reddit's r/stocks bear thread captured the same logic in numbers, pegging price-to-sales at roughly 67x even at the $160 reference level the IPO blew past, against Nvidia at 24x, Broadcom at 31x, and AMD at 9x. The bull-bear gap here isn't about whether wafer-scale is impressive; it's about how much of the AI compute pie a 'dinner-plate-sized' chip can plausibly eat.

The headline number is $5.55 billion raised ^[4]. The more interesting number is buried in the prospectus: OpenAI holds a warrant for up to 33.4 million Class N shares with an exercise price of $0.00001, vesting as Cerebras delivers committed inference capacity. At the IPO opening price of $385, the fully-vested warrant is worth roughly $11.7 billion ^[4]. That is more than twice what the company raised from public investors, handed to its largest customer for essentially zero cash.

The economics make the OpenAI relationship less of a contract and more of an equity partnership stapled to a procurement deal. Cerebras gets revenue visibility — the January 2026 Master Relationship Agreement covers 750 MW of inference capacity, expandable to 2 GW by 2030, against a stated $20B+ commitment ^[4]. OpenAI gets cheap upside in its key inference supplier and a structural reason to keep buying. Public shareholders get the residual: their stake in whatever cash flow remains after a customer with an embedded option has been served first. Michael Sikand's retail-investor breakdown on YouTube treated this single contract as essentially the entire bull case, which is also the entire concentration risk dressed up as a moat.

Strip out the wafer talk and Cerebras's 2025 revenue is, at the customer level, two phone numbers in the UAE. MBZUAI accounted for 62% of revenue and G42 for another 24% — together 86% — both linked to the Abu Dhabi tech complex; G42 also wrote a $335M equity check ^[5]. The S-1 lists the dependency in plain language: 'The loss of, any substantial reduction in sales to, or the default on payments by, any of our significant customers would harm our business' ^[5].

The risk isn't theoretical. TechTimes flags geopolitical tensions in the Middle East and a potential tightening of U.S. export controls as material risks ^[5], both of which can be triggered by Washington with a stroke of a pen. The OpenAI and AWS deals announced in early 2026 are the company's answer — diversification by hyperscaler — but most of that revenue is still in the future, while 86% of the revenue underwriting today's valuation is in the past, and routed through a region whose access to advanced AI chips has been a recurring political flashpoint. On Reddit, the older 'G42 will get you' thesis dominated the bear case and was the single most repeated reason commenters cited for staying out of the offering.

More than the company itself, what Wall Street is buying is the comp. The Cerebras book was reportedly more than 20x oversubscribed ^[6], and CNBC immediately framed the debut as a green light for the next wave of mega-IPOs — SpaceX, OpenAI, and Anthropic among them — while warning that all the oxygen could crowd out smaller AI players hoping to list this year ^[7]. EE Times made the parallel point on the private-market side: a credible non-Nvidia exit revives venture appetite for AI silicon startups that had stalled since 2024 ^[8].

The community read was sharper, and less polite. Threads on r/wallstreetbets and r/stocks gravitated to one frame: 'the bankers cooked it.' The marketed range walked from $115-125 to $150-160 to a final $185 in roughly a week, the offering ended up 20x+ oversubscribed, and most retail commenters reported they could not get allocations at any size. The same threads were already pricing a Wall Street-style follow-up trade — long at-the-money puts dated through the six-month insider lockup window, with options listings expected around May 18, 2026, and adjacent AI-capex plays like NBIS and APLD floated as cheaper exposure. Whatever Cerebras itself does next, the IPO has already rewritten the playbook for how 2026's biggest private AI names will be priced — and who will be allowed in the room.